Last updated on December 2018

Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors


Contact Investigators or Research Sites near you

Start Over

MD Anderson

Houston, TX United States
  Connect »

START

San Antonio, TX United States
  Connect »

University of Arizona

Tucson, AZ United States
  Connect »

Georgetown

Washington, WA United States
  Connect »

Johns Hopkins

Baltimore, MD United States
  Connect »

BIDMC

Boston, MA United States
  Connect »

DFCI

Boston, MA United States
  Connect »

Henry Ford

Detroit, MI United States
  Connect »

Vanderbilt

Nashville, TN United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.